{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T12:01:43Z","timestamp":1772798503157,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T00:00:00Z","timestamp":1536105600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Prostate Cancer Prostatic Dis"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1038\/s41391-018-0089-y","type":"journal-article","created":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T14:01:44Z","timestamp":1536156104000},"page":"143-149","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Impact of family history of cancer on risk and mortality of second cancers in patients with prostate cancer"],"prefix":"10.1038","volume":"22","author":[{"given":"Subhayan","family":"Chattopadhyay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Otto","family":"Hemminki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asta","family":"F\u00f6rsti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Sundquist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Sundquist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kari","family":"Hemminki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,5]]},"reference":[{"key":"89_CR1","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.canlet.2015.08.014","volume":"369","author":"T Chen","year":"2015","unstructured":"Chen T, Fallah M, Jansen L, Castro FA, Krilavicuite A, Katalinic A et al. Distribution and risk of the second discordant primary cancers combined after a specific first primary cancer in German and Swedish cancer registries. Cancer Lett 2015;369:152\u2013166.","journal-title":"Cancer Lett"},{"key":"89_CR2","volume-title":"Cancer incidence in Sweden 2012","author":"CentreforEpidemiology.","year":"2013","unstructured":"CentreforEpidemiology. Cancer incidence in Sweden 2012. Stockholm: The National Board of Health and Welfare; 2013."},{"key":"89_CR3","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/nrclinonc.2013.41","volume":"10","author":"LB Travis","year":"2013","unstructured":"Travis LB, Demark Wahnefried W, Allan JM, Wood ME, Ng AK. Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors. Nat Rev Clin Oncol. 2013;10:289\u2013301.","journal-title":"Nat Rev Clin Oncol"},{"key":"89_CR4","doi-asserted-by":"publisher","first-page":"3734","DOI":"10.1200\/JCO.2012.41.8681","volume":"30","author":"ME Wood","year":"2012","unstructured":"Wood ME, Vogel V, Ng A, Foxhall L, Goodwin P, Travis LB. Second malignant neoplasms: assessment and strategies for risk reduction. J Clin Oncol 2012;30:3734\u20133745.","journal-title":"J Clin Oncol"},{"key":"89_CR5","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1056\/NEJMoa1505949","volume":"373","author":"M Schaapveld","year":"2015","unstructured":"Schaapveld M, Aleman BM, van Eggermond AM, Janus CP, Krol AD, van der Maazen RW et al. Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma. N Engl J Med 2015;373:2499\u20132511.","journal-title":"N Engl J Med"},{"key":"89_CR6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1634\/theoncologist.2010-0338","volume":"16","author":"M Riihimaki","year":"2011","unstructured":"Riihimaki M, Thomsen H, Brandt A, Sundquist J, Hemminki K. What do prostate cancer patients die of? Oncologist. 2011;16:175\u201381.","journal-title":"Oncologist"},{"key":"89_CR7","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1002\/cncr.30164","volume":"122","author":"N Donin","year":"2016","unstructured":"Donin N, Filson C, Drakaki A, Tan HJ, Castillo A, Kwan L et al. Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008. Cancer 2016;122: 3075\u20133086.","journal-title":"Cancer"},{"key":"89_CR8","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/annonc\/mdw604","volume":"28","author":"NG Zaorsky","year":"2017","unstructured":"Zaorsky NG, Churilla TM, Egleston BL, Fisher SG, Ridge JA, Horwitz EM et al. Causes of death among cancer patients. Ann Oncol 2017;28:400-407.","journal-title":"Ann Oncol"},{"key":"89_CR9","doi-asserted-by":"publisher","first-page":"e000172","DOI":"10.1136\/esmoopen-2017-000172","volume":"2","author":"A Vogt","year":"2017","unstructured":"Vogt A, et al. Multiple primary tumours: challenges and approaches, a review. ESMO Open. 2017;2:e000172.","journal-title":"ESMO Open"},{"key":"89_CR10","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s00345-016-1934-z","volume":"35","author":"A Keehn","year":"2017","unstructured":"Keehn A, Ludmir E, Taylor J, Rabbani F. Incidence of bladder cancer after radiation for prostate cancer as a function of time and radiation modality. World J Urol. 2017;35:713\u201320.","journal-title":"World J Urol"},{"key":"89_CR11","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1159\/000356115","volume":"93","author":"T Jin","year":"2014","unstructured":"Jin T, Song T, Deng S, Wang K. Radiation-induced secondary malignancy in prostate cancer: a systematic review and meta-analysis. Urol Int. 2014;93:279\u201388.","journal-title":"Urol Int"},{"key":"89_CR12","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1002\/ijc.22414","volume":"120","author":"O Landgren","year":"2007","unstructured":"Landgren O, Pfeiffer RM, Stewart L, Gridley G, Mellemkjaer L, Hemminki K et al. Risk of second malignant neoplasms among lymphoma patients with a family history of cancer. Int J Cancer 2007;120:1099\u20131102.","journal-title":"Int J Cancer"},{"key":"89_CR13","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1200\/JCO.2016.70.9709","volume":"35","author":"A Sud","year":"2017","unstructured":"Sud A, Thomsen H, Sundquist K, Houlston RS, Hemminki K. Risk of second cancer in Hodgkin lymphoma survivors and the influence of family history. J Clin Oncol. 2017;35:1584\u201390.","journal-title":"J Clin Oncol"},{"key":"89_CR14","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1002\/ijc.30583","volume":"140","author":"C Frank","year":"2017","unstructured":"Frank C, Sundquist J, Yu H, Hemminki A, Hemminki K. Concordant and discordant familial cancer: familial risks, proportions and population impact. Int J Cancer. 2017;140:1510\u20136.","journal-title":"Int J Cancer"},{"key":"89_CR15","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1002\/ijc.24795","volume":"126","author":"K Hemminki","year":"2010","unstructured":"Hemminki K, Ji J, Brandt A, Mousavi SM, Sundquist J. The Swedish Family-Cancer Database 2009: prospects for histology-specific and immigrant studies. Int J Cancer. 2010;126:2259\u201367.","journal-title":"Int J Cancer"},{"key":"89_CR16","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1093\/jnci\/dji338","volume":"97","author":"J Lorenzo Bermejo","year":"2005","unstructured":"Lorenzo Bermejo J, Hemminki K. Familial risk of cancer shortly after diagnosis of the first familial tumor. J Natl Cancer Inst. 2005;97:1575\u20139.","journal-title":"J Natl Cancer Inst"},{"key":"89_CR17","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1007\/s00345-012-1021-z","volume":"31","author":"K Hemminki","year":"2013","unstructured":"Hemminki K, Ankerst DP, Sundquist J, Mousavi SM. Prostate cancer incidence and survival in immigrants to Sweden. World J Urol. 2013;31:1483\u20138.","journal-title":"World J Urol"},{"key":"89_CR18","unstructured":"Centre for Epidemiology. Cancer Incidence in Sweden 1990. The National Board of Health and Welfare; 1993. p. 139."},{"key":"89_CR19","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1016\/j.ejca.2015.07.027","volume":"51","author":"A Trama","year":"2015","unstructured":"Trama A, Foschi R, Larranaga N, Sant M, Fuentes-Raspall R, Serraino D et al. Survival of male genital cancers (prostate, testis and penis) in Europe 1999-2007: Results from the EUROCARE-5 study. Eur J Cancer 2015;51:2206\u20132216.","journal-title":"Eur J Cancer"},{"key":"89_CR20","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1002\/ijc.27462","volume":"131","author":"J Ji","year":"2012","unstructured":"Ji J, Sundquist K, Sundquist J, Hemminki K. Comparability of cancer identification among Death Registry, Cancer Registry and Hospital Discharge Registry. Int J Cancer. 2012;131:2085\u201393.","journal-title":"Int J Cancer"},{"key":"89_CR21","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nature12981","volume":"505","author":"N Rahman","year":"2014","unstructured":"Rahman N. Realizing the promise of cancer predisposition genes. Nature. 2014;505:302\u20138.","journal-title":"Nature"},{"key":"89_CR22","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1200\/JCO.2017.74.1173","volume":"36","author":"VN Giri","year":"2017","unstructured":"Giri VN, Knudsen KE, Kelly WK, Abida W, Andriole GL, Bangma CH et al. Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017. J Clin Oncol. 2018;36:4,\u00a0414\u2013424\u00a0","journal-title":"J Clin Oncol"},{"key":"89_CR23","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1136\/gutjnl-2017-314057","volume":"67","author":"P Moller","year":"2017","unstructured":"Moller P, Seppala TT, Bernstein I, Holinski-Feder E, Sala P, Gareth Evans D et al. Cancer risk and survival in\u00a0path_MMR\u00a0carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database. Gut\u00a02018;67:1306\u20131316.","journal-title":"Gut"},{"key":"89_CR24","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.eururo.2016.07.031","volume":"71","author":"C Frank","year":"2017","unstructured":"Frank C, Sundquist J, Hemminki A, Hemminki K. Familial associations between prostate cancer and other cancers. Eur Urol. 2017;71:162\u20135.","journal-title":"Eur Urol"},{"key":"89_CR25","doi-asserted-by":"crossref","unstructured":"Yu H, Frank C, Hemminki A, Sundquist K, Hemminki K. Other cancers in lung cancer families are overwhelmingly smoking-related cancers.\u00a0ERJ Open Research. 2017;3:00006\u201302017.","DOI":"10.1183\/23120541.00006-2017"},{"key":"89_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-05732-z","volume":"7","author":"H Yu","year":"2017","unstructured":"Yu H, Hemminki A, Sundquist K, Hemminki K. Familial associations of colorectal cancer with other cancers. Sci Rep. 2017;7:5243.","journal-title":"Sci Rep"},{"key":"89_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/srep42601","volume":"7","author":"C Frank","year":"2017","unstructured":"Frank C, Sundquist J, Hemminki A, Hemminki K. Risk of other cancers in families with melanoma: novel familial links. Sci Rep. 2017;7:42601.","journal-title":"Sci Rep"},{"key":"89_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-21410-0","volume":"8","author":"K Hemminki","year":"2018","unstructured":"Hemminki K, Hemminki O, F\u00f6rsti A, Sundquist J, Sundquist K, Li X. Familial Risks Between Urolithiasis and Cancer. Scientific Reports 2018;8:3083.","journal-title":"Sci Rep"},{"key":"89_CR29","doi-asserted-by":"publisher","first-page":"365","DOI":"10.2217\/pme.11.15","volume":"8","author":"J Gu","year":"2011","unstructured":"Gu J, Wu X. Genetic susceptibility to bladder cancer risk and outcome. Pers Med. 2011;8:365\u201374.","journal-title":"Pers Med"},{"key":"89_CR30","doi-asserted-by":"publisher","first-page":"4394","DOI":"10.1200\/JCO.2013.51.1915","volume":"31","author":"WQ Li","year":"2013","unstructured":"Wen-Qing Li,\u00a0Abrar A. Qureshi,\u00a0Jing Ma,\u00a0Alisa M. Goldstein,\u00a0Edward L. Giovannucci,\u00a0Meir J. Stampfer, and\u00a0Jiali Han. J Clin Oncol. 2013;31:35,4394\u201399","journal-title":"J Clin Oncol"},{"key":"89_CR31","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1093\/annonc\/mdr536","volume":"23","author":"K Hemminki","year":"2012","unstructured":"Hemminki K, Bevier M, Hemminki A, Sundquist J. Survival in cancer of unknown primary site: population-based analysis by site and histology. Ann Oncol. 2012;23:1854\u201363.","journal-title":"Ann Oncol"},{"key":"89_CR32","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/ijc.27988","volume":"133","author":"K Hemminki","year":"2013","unstructured":"Hemminki K, Riihimaki M, Sundquist K, Hemminki A. Site-specific survival rates for cancer of unknown primary according to location of metastases. Int J Cancer. 2013;133:182\u20139.","journal-title":"Int J Cancer"},{"key":"89_CR33","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1093\/annonc\/mds063","volume":"23","author":"K Hemminki","year":"2012","unstructured":"Hemminki K, Bevier M, Sundquist J, Hemminki A. Cancer of unknown primary (CUP): does cause of death and family history implicate hidden phenotypically changed primaries? Ann Oncol. 2012;23:2720\u201324.","journal-title":"Ann Oncol"},{"key":"89_CR34","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/pros.23396","volume":"77","author":"CJ Paller","year":"2017","unstructured":"Paller CJ, Cole AP, Partin AW, Carducci MA, Kanarek NF. Risk factors for metastatic prostate cancer: a sentinel event case series. Prostate. 2017;77:1366\u201372.","journal-title":"Prostate"},{"key":"89_CR35","unstructured":"IARC. Personal habits and indoor combustion. Lyon: International Agency for Research on Cancer; 2012. p. 575."}],"container-title":["Prostate Cancer and Prostatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41391-018-0089-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41391-018-0089-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41391-018-0089-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T23:34:35Z","timestamp":1720568075000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41391-018-0089-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,5]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["89"],"URL":"https:\/\/doi.org\/10.1038\/s41391-018-0089-y","relation":{},"ISSN":["1365-7852","1476-5608"],"issn-type":[{"value":"1365-7852","type":"print"},{"value":"1476-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,5]]},"assertion":[{"value":"25 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}